版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請進行舉報或認(rèn)領(lǐng)
文檔簡介
1、三尖瓣封鎖不全的外科處置三尖瓣封鎖不全的外科處置LU Shuyang;The tricuspid valve:a neglected valvular lesion;History mitral valve replacement alone leads to resolution of severe functional tricuspid regurgitation and therefore tricuspid valve surgery was not indicated. mid-1960s by Braunwald et al the opposing view of routin
2、e valve repair for functional tricuspid regurgitation. late 1960s by Carpentier et al annuloplasty at the initial mitral valve operation in the 1970s;Tricuspid anatomy;Tricuspid physiologylThe closing mechanism of the tricuspid valve mainly depends on right ventricular contractilitylLeft-sided valvu
3、lar lesions may influence tricuspid valve functionlPhysiological changes of tricuspid valve ring during cardiac cycle ;Mechanisms of significanttricuspid regurgitation;Stages of primary and functional TR(Stage A-B) ;Stages of primary and functional TR(Stage C-D) ;Indications of TR Surgery2021 AHA/AC
4、C Guideline;Indications of TR Surgery2021 AHA/ACC Guideline;Valve repair Annuloplasty1. Reduction of the annulus without support2. Annular reduction supported by sutures3. Selective reduction supported by strips or pledgets of synthetic material4. Annular reduction by different types of prosthetic r
5、ings;De Vega annuloplasty1. Preservation of valvular mechanism2. It maintains the physiological flexibility of the annulus3. No prosthetic material is required4. No damage to the conduction tissue5. It is easy, fast to perform, cheapClassical De VegaModification of De Vega;Classical De Vega annulopl
6、asty;Why we need Annuloplasty ringslCorrection of annular dilatationlRemodelling the shape of the annuluslImprove coaptation between leaflets during systolelStabilization of repair over time;Annuloplasty ringsEdwards MC3Standard CarpentierEdwards.;Biodegradable ringlPoly-1,4-dioxanone polymer curved
7、 C-shaped ring and suture material extensions at each endlIts specific molecular weight provides structural memory to protect it from subsequent deformity ;Biodegradable ring Preservation of the potential for growth of the mitral annulus (pediatric population) No synthetic material (less risk of end
8、ocarditis) No need for anticoagulation during the first three postoperative months Easy implantation technique (reduction in the duration of aortic cross clamp and ECC);Tricuspid valve replacement;TVR OR TVP?;Rheumatic heart diseasePatients47Period1977 2021Mean age59.011.4yGenderM19.1% F80.9%Atrial
9、fibrillation80.9%;Two groups according to tricuspid valve surgeryRepair n = 18 (38.3%)Replacement n = 29 (61.7%);TVReplacementTVrepairAge59.913.662.35.5Range21 7653 - 76Female 23 (79.3%)15 (83.3%)Weight59.611.566.510.3Height157.36.5160.97.4Body surface area24.14.425.73.5;TVReplacementTVrepairAtrial
10、fibrillation27 (93.1%)14 (77.8%)Cardiac index2.00.72.10.3PA sistolic pressure43.313.742.711.3Pulmonary capillary pressure26.52.421.74.2Left ventricular EF57.810.154.311.7Mean TV regurgitation3.573.55;TVReplacementTVrepairPrevious TV surgery Repair7 (24.1%)2 (11.1%) Replacement 4 (13.8%)-Previous CPB
11、 operations One11 (37.9%)6 (33.3%) Two9 (31.0%)2 (11.1%) Three2 (6.9%)-;TVReplacementTVrepairNYHA class III7 (24.1%)12 (66.7%)NYHA class IV19 (65.5%)4 (22.2%);TRICUSPID REPAIRDe Vega annuloplasty (8 pts)Duran ring annuloplasty (10 pts)Commissurotomy (2 pts)TRICUSPID REPLACEMENTMechanical valve (14 p
12、ts)Bioprosthesis (15 pts);Follow-upComplete follow-up97.8%Mean follow-up16.2 yearsRange1 month 33 years;TVReplacementTVrepairCPB time79.942.875.745.7Ischemic time21.823.164.548.8Mortality8 (27.6%)- Cardiac6 Bleeding1 Neurologic1;TVReplacementTVrepairLate mortality15 (51.7%)9 (50.0%) Cardiac23 Valvul
13、ar11 Unknown71 Reoperation12 Thromboembolism1 Hemorrhage1 Malignacy1 Others non cardiac21Late results;Survival;Freedom from reoperation;TVR n = 29Alive 20.7%Class I2Class II3Class III1Repair n = 18Alive 50.0%Class I3Class II4Class III2;1.Isolated tricuspid valve surgery with normal functioning left side valve occurs after mitral and/or aortic valve surgery2.Isolated tricuspid valve surgery has a high early and late mortality due to cardiac causes3.Tricuspid valve replacement entails a worse result comparing with tricu
溫馨提示
- 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 人人文庫網(wǎng)僅提供信息存儲空間,僅對用戶上傳內(nèi)容的表現(xiàn)方式做保護處理,對用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對任何下載內(nèi)容負(fù)責(zé)。
- 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時也不承擔(dān)用戶因使用這些下載資源對自己和他人造成任何形式的傷害或損失。
最新文檔
- 2025年項目管理流程與方法指南-1
- 企業(yè)環(huán)境保護管理制度與操作手冊
- 電影院廣告宣傳與播放規(guī)定制度
- 人力資源管理創(chuàng)新與效能提升(標(biāo)準(zhǔn)版)
- 超市員工福利及慰問制度
- 菜地管理規(guī)章制度
- 辦公室員工培訓(xùn)效果評估反饋制度
- 養(yǎng)老院老人健康監(jiān)測報告制度
- 中國東方電氣集團有限公司2025年校園招聘備考題庫有答案詳解
- 養(yǎng)老院家屬探訪制度
- 教師三筆字培訓(xùn)課件
- (正式版)HGT 22820-2024 化工安全儀表系統(tǒng)工程設(shè)計規(guī)范
- 京港澳高速公路段改擴建工程施工保通方案(總方案)
- 醫(yī)用設(shè)備EMC培訓(xùn)資料課件
- RoHS培訓(xùn)資料課件
- 2020年廣東學(xué)位英語考試真題及答案
- 鍋爐防磨防爆工作專項檢查方案
- 《儀表本安防爆技術(shù)》課件
- Q∕SY 01869-2020 稠油油藏SAGD開發(fā)技術(shù)規(guī)范
- 協(xié)調(diào)控制系統(tǒng)
- 消防報警系統(tǒng)線路設(shè)計檢查和安裝質(zhì)量檢查記錄
評論
0/150
提交評論